sorbitol has been researched along with miglitol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gunji, E; Jingu, S; Kinoshita, K; Mizuno-Yasuhira, A; Nakai, Y; Sakai, S; Samukawa, Y; Takahashi, T; Uchida, S; Yamaguchi, J | 1 |
| Fukatsu, A; Sakai, S; Samukawa, Y; Sasaki, T; Seino, Y; Ubukata, M | 1 |
| Chen, L; Hu, ZC; Ke, X; Pan-Hong, Y; Sun, XQ; Zheng, YG | 1 |
| Honda, Y; Imajo, K; Iwaki, M; Kessoku, T; Kobayashi, T; Nagashima, Y; Nakajima, A; Nogami, A; Ogawa, Y; Ozaki, A; Saito, S; Tomeno, W; Yoneda, M | 1 |
1 review(s) available for sorbitol and miglitol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for sorbitol and miglitol
| Article | Year |
|---|---|
Absence of Drug-Drug Interactions Between Luseogliflozin, a Sodium-Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males.
Topics: 1-Deoxynojirimycin; Adult; Antihypertensive Agents; Area Under Curve; Cross-Over Studies; Female; Humans; Hypoglycemic Agents; Japan; Male; Metformin; Middle Aged; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Sorbitol; Sulfonylurea Compounds; Thiazolidinediones; Triazoles | 2015 |
3 other study(ies) available for sorbitol and miglitol
| Article | Year |
|---|---|
A Strategy for assessing potential drug-drug interactions of a concomitant agent against a drug absorbed via an intestinal transporter in humans.
Topics: 1-Deoxynojirimycin; Animals; Cell Line; CHO Cells; Computer Simulation; Cricetulus; Drug Interactions; Humans; Intestinal Absorption; Intestinal Mucosa; Male; Membrane Transport Proteins; Models, Biological; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 1; Sorbitol | 2014 |
Synergistic improvement of PQQ-dependent D-sorbitol dehydrogenase activity from Gluconobacter oxydans for the biosynthesis of miglitol precursor 6-(N-hydroxyethyl)-amino-6-deoxy-α-L-sorbofuranose.
Topics: 1-Deoxynojirimycin; Amino Acids; Bacterial Proteins; Bioreactors; Culture Media; Fermentation; Gene Expression; Gluconobacter oxydans; Hypoglycemic Agents; L-Iditol 2-Dehydrogenase; PQQ Cofactor; Recombinant Proteins; Sorbitol; Sorbose | 2019 |
Protective effect of SGL5213, a potent intestinal sodium-glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice.
Topics: 1-Deoxynojirimycin; Animals; Chronic Disease; Diet, High-Fat; Dietary Sucrose; Disease Models, Animal; Gastrointestinal Absorption; Gene Expression; Glucose; Insulin Resistance; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Patient Acuity; RNA, Messenger; Sodium-Glucose Transporter 1; Sorbitol | 2021 |